Prognostic value of candidate microRNAs in gastric cancer: A validation study

Torre L.A. , Bray F. , Siegel R.L. , Ferlay J. , Lortet-Tieulent J. and Jemal A. , Global cancer statistics, 2012, CA Cancer J Clin 65 (2015), 87-108.

Chen W. , Zheng R. , Baade P.D. , Zhang S. , Zeng H. , Bray F. , Jemal A. , Yu X.Q. and He J. , Cancer statistics in China, 2015, CA Cancer J Clin 66 (2016), 115-32.

Tsai M.M. , Wang C.S. , Tsai C.Y. , Huang H.W. , Chi H.C. , Lin Y.H. , Lu P.H. and Lin K.H. , Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer, Int J Mol Sci 17 (2016).

Li R. , Zhang H. , Liu H. , Lin C. , Cao Y. , Zhang W. , Shen Z. and Xu J. , High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection, Oncotarget (2016).

Lim B. , Kim J.H. , Kim M. and Kim S.Y. , Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer, World J Gastroenterol 22 (2016), 1190-201.

Zhou X. , Zhu W. , Li H. , Wen W. , Cheng W. , Wang F. , Wu Y. , Qi L. , Fan Y. , Chen Y. , Ding Y. , Xu J. , Qian J. , Huang Z. , Wang T. , Zhu D. , Shu Y. and Liu P. , Diagnostic value of a plasma microRNA signature in gastric cancer: A microRNA expression analysis, Sci Rep 5 (2015), 11251.

Doench J.G. and Sharp P.A. , Specificity of microRNA target selection in translational repression, Genes Dev 18 (2004), 504-11.

Hausser J. and Zavolan M. , Identification and consequences of miRNA-target interactions-beyond repression of gene expression, Nat Rev Genet 15 (2014), 599-612.

Nicoloso M.S. , Spizzo R. , Shimizu M. , Rossi S. and Calin G.A. , MicroRNAs - the micro steering wheel of tumour metastases, Nat Rev Cancer 9 (2009), 293-302.

Yan W. , Qian L. , Chen J. , Chen W. and Shen B. , Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer, J Cancer 7 (2016), 95-106.

Wu H.H. , Lin W.C. and Tsai K.W. , Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers, Expert Rev Mol Med 16 (2014), e1.

Li H. , Zhou X. , Zhu J. , Cheng W. , Zhu W. , Shu Y. and Liu P. , MiR-4728-3p could act as a marker of HER2 status, Cancer Biomark 15 (2015), 807-14.

Zhao D.S. , Chen Y. , Jiang H. , Lu J.P. , Zhang G. , Geng J. , Zhang Q. , Shen J.H. , Zhou X. , Zhu W. and Shan Q.J. , Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure, Cardiovasc Pathol 22 (2013), 444-50.

Qiu T. , Zhou X. , Wang J. , Du Y. , Xu J. , Huang Z. , Zhu W. , Shu Y. and Liu P. , MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer, FEBS Lett 588 (2014), 1168-77.

Livak K.J. and Schmittgen T.D. , Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25 (2001), 402-8.

Li X. , Zhang Y. , Zhang Y. , Ding J. , Wu K. and Fan D. , Survival prediction of gastric cancer by a seven-microRNA signature, Gut 59 (2010), 579-85.

Jiang J. , Zheng X. , Xu X. , Zhou Q. , Yan H. , Zhang X. , Lu B. , Wu C. and Ju J. , Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin, PLoS One 6 (2011), e23271.

Kim B.H. , Hong S.W. , Kim A. , Choi S.H. and Yoon S.O. , Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma, J Surg Oncol 107 (2013), 505-10.

Osawa S. , Shimada Y. , Sekine S. , Okumura T. , Nagata T. , Fukuoka J. and Tsukada K. , MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples, Oncol Lett 2 (2011), 613-619.

Valladares-Ayerbes M. , Blanco M. , Haz M. , Medina V. , Iglesias-Diaz P. , Lorenzo-Patino M.J. , Reboredo M. , Santamarina I. , Figueroa A. , Anton-Aparicio L.M. and Calvo L. , Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer, Int J Oncol 39 (2011), 1253-64.

Komatsu S. , Ichikawa D. , Tsujiura M. , Konishi H. , Takeshita H. , Nagata H. , Kawaguchi T. , Hirajima S. , Arita T. , Shiozaki A. , Kubota T. , Fujiwara H. , Okamoto K. and Otsuji E. , Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma, Anticancer Res 33 (2013), 271-6.

Park J.L. , Kim M. , Song K.S. , Kim S.Y. and Kim Y.S. , Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer, Genomics Inform 13 (2015), 70-5.

Wang M. , Gu H. , Wang S. , Qian H. , Zhu W. , Zhang L. , Zhao C. , Tao Y. and Xu W. , Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer, Mol Med Rep 5 (2012), 1514-20.

Chen L. , Jiang M. , Yuan W. and Tang H. , Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas, Acta Gastroenterol Belg 75 (2012), 22-7.

Wei B. , Huang Q.Y. , Huang S.R. , Mai W. and Zhong X.G. , MicroRNA34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET, Mol Med Rep 12 (2015), 5255-61.

He M. , Gao L. , Zhang S. , Tao L. , Wang J. , Yang J. and Zhu M. , Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL, Gastric Cancer 17 (2014), 431-41.

Ma L. , Chen Y. , Zhang B. and Liu G. , Increased microRNA-223 in Helicobacter pylori-associated gastric cancer contributed to cancer cell proliferation and migration, Biosci Biotechnol Biochem 78 (2014), 602-8.

Valladares-Ayerbes M. , Reboredo M. , Medina-Villaamil V. , Iglesias-Diaz P. , Lorenzo-Patino M.J. , Haz M. , Santamarina I. , Blanco M. , Fernandez-Tajes J. , Quindos M. , Carral A. , Figueroa A. , Anton-Aparicio L.M. and Calvo L. , Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer, J Transl Med 10 (2012), 186.

Tang H. , Deng M. , Tang Y. , Xie X. , Guo J. , Kong Y. , Ye F. , Su Q. and Xie X. , miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression, Clin Cancer Res 19 (2013), 5602-12.

Blanco-Calvo M. , Tarrio N. , Reboredo M. , Haz-Conde M. , Garcia J. , Quindos M. , Figueroa A. , Anton-Aparicio L. , Calvo L. and Valladares-Ayerbes M. , Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer, Future Oncol 10 (2014), 1187-202.

Inoue T. , Iinuma H. , Ogawa E. , Inaba T. and Fukushima R. , Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer, Oncol Rep 27 (2012), 1759-64.

Li X. , Zhang Y. , Shi Y. , Dong G. , Liang J. , Han Y. , Wang X. , Zhao Q. , Ding J. , Wu K. and Fan D. , MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer, J Cell Mol Med 15 (2011), 1887-95.

Hou Z. , Xie L. , Yu L. , Qian X. and Liu B. , MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis, Med Oncol 29 (2012), 886-92.

Kogo R. , Mimori K. , Tanaka F. , Komune S. and Mori M. , Clinical significance of miR-146a in gastric cancer cases, Clin Cancer Res 17 (2011), 4277-84.

Liu K. , Li G. , Fan C. , Diao Y. , Wu B. and Li J. , Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance, J Int Med Res 40 (2012), 467-74.

Fu Z. , Qian F. , Yang X. , Jiang H. , Chen Y. and Liu S. , Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer, Med Oncol 31 (2014), 164.

Tan Z. , Jiang H. , Wu Y. , Xie L. , Dai W. , Tang H. and Tang S. , miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer, Mol Cell Biochem 386 (2014), 223-31.

Wang Y.Y. , Ye Z.Y. , Zhao Z.S. , Li L. , Wang Y.X. , Tao H.Q. , Wang H.J. and He X.J. , Clinicopathologic significance of miR-10b expression in gastric carcinoma, Hum Pathol 44 (2013), 1278-85.

Yang Q. , Zhang C. , Huang B. , Li H. , Zhang R. , Huang Y. and Wang J. , Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer, Eur J Gastroenterol Hepatol 25 (2013), 953-7.

Shi H. , Han J. , Yue S. , Zhang T. , Zhu W. and Zhang D. , Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study, Biomed Pharmacother 71 (2015), 210-5.

Mu Y.P. , Tang S. , Sun W.J. , Gao W.M. , Wang M. and Su X.L. , Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer, Asian Pac J Cancer Prev 15 (2014), 8893-900.

Tsai M.M. , Wang C.S. , Tsai C.Y. , Chen C.Y. , Chi H.C. , Tseng Y.H. , Chung P.J. , Lin Y.H. , Chung I.H. , Chen C.Y. and Lin K.H. , MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer, Cancer Lett 351 (2014), 222-31.

Huang D. , Wang H. , Liu R. , Li H. , Ge S. , Bai M. , Deng T. , Yao G. and Ba Y. , miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer, J Cell Biochem 115 (2014), 549-56.

Wang Y. , Zhang Y. , Pan C. , Ma F. and Zhang S. , Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: A meta-analysis, PLoS One 10 (2015), e0118647.

Yang J.S. , Li B.J. , Lu H.W. , Chen Y. , Lu C. , Zhu R.X. , Liu S.H. , Yi Q.T. , Li J. and Song C.H. , Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening, Tumour Biol 36 (2015), 3035-42.

Zhu W. and Xu B. , MicroRNA-21 identified as predictor of cancer outcome: A meta-analysis, PLoS One 9 (2014), e103373.

Chen Z. , Liu H. , Jin W. , Ding Z. , Zheng S. and Yu Y. , Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysis, Onco Targets Ther 9 (2016), 2615-24.

Zhang Z. , Li Z. , Gao C. , Chen P. , Chen J. , Liu W. , Xiao S. and Lu H. , miR-21 plays a pivotal role in gastric cancer pathogenesis and progression, Lab Invest 88 (2008), 1358-66.

Li L. , Zhou L. , Li Y. , Lin S. and Tomuleasa C. , MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog, J BUON 19 (2014), 228-36.

Yang Q. , Xu E. , Dai J. , Wu J. , Zhang S. , Peng B. and Jiang Y. , miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2, Toxicol Lett 228 (2014), 147-56.

Sayed D. , Rane S. , Lypowy J. , He M. , Chen I.Y. , Vashistha H. , Yan L. , Malhotra A. , Vatner D. and Abdellatif M. , MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths, Mol Biol Cell 19 (2008), 3272-82.

Korpal M. , Lee E.S. , Hu G. and Kang Y. , The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2, J Biol Chem 283 (2008), 14910-4.

Hayashita Y. , Osada H. , Tatematsu Y. , Yamada H. , Yanagisawa K. , Tomida S. , Yatabe Y. , Kawahara K. , Sekido Y. and Takahashi T. , A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, Cancer Res 65 (2005), 9628-32.

Ma H. , Pan J.S. , Jin L.X. , Wu J. , Ren Y.D. , Chen P. , Xiao C. and Han J. , MicroRNA-17∼ 92 inhibits colorectal cancer progression by targeting angiogenesis, Cancer Lett (2016).

Bertoli G. , Cava C. and Castiglioni I. , MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer, Theranostics 5 (2015), 1122-43.